Enhanced endocannabinoid signaling elevates neuronal excitability in fragile X syndrome.
about
Synaptic Plasticity, a Prominent Contributor to the Anxiety in Fragile X SyndromeThe function of metabotropic glutamate receptors in thalamus and cortexThe contribution of inhibitory interneurons to circuit dysfunction in Fragile X SyndromeThe pathophysiology of fragile X (and what it teaches us about synapses)GABAergic signaling as therapeutic target for autism spectrum disordersNeuroligins provide molecular links between syndromic and nonsyndromic autismTargeted pharmacological treatment of autism spectrum disorders: fragile X and Rett syndromesUncoupling of the endocannabinoid signalling complex in a mouse model of fragile X syndromeThe role of fragile X mental retardation protein in major mental disorders.Endogenous cannabinoid signaling at inhibitory interneurons.Fragile X targeted pharmacotherapy: lessons learned and future directions.Dysregulation of group-I metabotropic glutamate (mGlu) receptor mediated signalling in disorders associated with Intellectual Disability and AutismDeficient tonic GABAergic conductance and synaptic balance in the fragile X syndrome amygdalaEndocannabinoid signaling and synaptic function.Cell-specific STORM super-resolution imaging reveals nanoscale organization of cannabinoid signaling.Homer protein-metabotropic glutamate receptor binding regulates endocannabinoid signaling and affects hyperexcitability in a mouse model of fragile X syndrome.Impaired inhibitory control of cortical synchronization in fragile X syndrome.Therapeutic strategies in fragile X syndrome: dysregulated mGluR signaling and beyond.Fragile X syndrome: the GABAergic system and circuit dysfunction.Targeted treatments for fragile X syndrome.Fmr1 KO and fenobam treatment differentially impact distinct synapse populations of mouse neocortex.Sapap3 deletion anomalously activates short-term endocannabinoid-mediated synaptic plasticityPathological plasticity in fragile X syndrome.Genetic removal of p70 S6 kinase 1 corrects molecular, synaptic, and behavioral phenotypes in fragile X syndrome mice.Elevated CaMKIIα and Hyperphosphorylation of Homer Mediate Circuit Dysfunction in a Fragile X Syndrome Mouse Model.Fmr1 deletion enhances and ultimately desensitizes CB(1) signaling in autaptic hippocampal neurons.Fragile X syndrome: an aging perspective.Endocannabinoid-mediated improvement on a test of aversive memory in a mouse model of fragile X syndrome.Supply and demand for endocannabinoids.Distinct functions for direct and transthalamic corticocortical connections.Presynaptic long-term plasticityInterplay between synaptic endocannabinoid signaling and metaplasticity in neuronal circuit function and dysfunction.Muscarinic cholinergic receptors modulate inhibitory synaptic rhythms in hippocampus and neocortexDissecting the Signaling Pathways Involved in the Crosstalk between Metabotropic Glutamate 5 and Cannabinoid Type 1 Receptors.Getting high on the endocannabinoid system.Closing the gap: long-term presynaptic plasticity in brain function and disease.Synaptic functions of endocannabinoid signaling in health and disease.The Endocannabinoid System and Autism Spectrum Disorders: Insights from Animal Models.Excitability is increased in hippocampal CA1 pyramidal cells of Fmr1 knockout mice.Seizing an opportunity for the endocannabinoid system.
P2860
Q26745117-3C5010FA-107E-4939-BF0A-B25ABFFF3644Q26828004-319519D3-F395-423C-9E38-7E42E456A1C5Q26998540-78B8E917-78B3-4081-A052-BCDB92190468Q27010675-E0907DAA-A0A0-4309-B7D0-1E0BB0C063C7Q27013583-B87468D4-71EB-4DBA-979E-718A7AB1CBE8Q27015370-815C51E2-DECF-4071-B3E1-5FFBAFE53BA4Q27023257-5E37777C-7C07-434D-A38F-B75F65B3CE0EQ28585288-73667280-F88C-489E-BB0C-65894C7BA4C9Q30467175-B1A17F0B-3B72-437E-90CE-39C61E9DEB74Q33624983-36ABC259-4B39-4DF6-9374-3CAA82119FE9Q33785983-DF170941-0580-4A0A-81CA-7AA418AEA45AQ33877423-E4409E0F-3960-422F-B18E-9180A0C13C07Q34006575-7B123111-A742-44AA-808F-B69F31CB95BCQ34304094-F60C7E5C-FFDC-4EBF-B1AD-E983C513D18EQ34452582-90E9D758-CDB5-45DA-A03C-61E9F7D7F63EQ35142914-1DA8B0F3-92E1-4B89-9188-B689210EE05AQ35543947-1F3D5B57-F3CD-4EFA-98C6-D4FE6C2E588DQ35614072-00F670C2-4E88-4CB6-8038-458877F07211Q35661582-F71EBD47-9812-486F-AD01-12F4E1800824Q35680726-54882D2C-D435-41C5-97BE-4A2FE9046363Q35776690-E2859BAE-4321-4088-AE6A-2282B6025A48Q36008922-FE9681B4-0517-4CC1-8692-964F3A139C58Q36090455-5E88ED64-ACB6-494A-8450-8A158932B850Q36342394-C4537DEE-2680-4D42-BFCC-1FC610088BA9Q36387172-637A2778-25D2-4CDF-B2C4-868B035E0A44Q36984263-F5ED7C4A-A4CD-4C86-837D-3C5EED9E5086Q37122910-EAAA066E-2D58-4CBF-BE30-0437185D58CDQ37213114-19B024A8-DC52-472B-95F4-AA5F8C0B7ED2Q37867227-D5F67382-CF7F-489A-8D96-7B4E4F58796EQ37890145-E7BE29E8-DE6B-4054-818B-9E6E733BCF22Q38154568-C29B166D-79E3-4B90-A2A3-E3D1B2BDF765Q38203030-22027777-0A71-433B-8E9E-D95D4D9B1EE9Q38253634-13388FCB-C61C-44B3-AAD9-35735E63E51DQ38874824-9FA7B401-3E1E-48FC-B972-1F2F064F3EBEQ38926128-37466556-ECD2-47AE-9A6A-530DAD753CE6Q39344129-A443B0BF-FAA3-4E17-8DCF-9C7DA663099FQ39381131-8A051F19-D32A-41B0-9078-096AD7A10632Q41660878-3EC05F06-D237-4E86-B1AF-997F1FD35E8FQ42361556-97DE5644-0FA5-4775-816E-C2839ECDDD4EQ42935146-14238D7C-0008-4110-B27E-A0A7D8F9B308
P2860
Enhanced endocannabinoid signaling elevates neuronal excitability in fragile X syndrome.
description
2010 nî lūn-bûn
@nan
2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Enhanced endocannabinoid signaling elevates neuronal excitability in fragile X syndrome.
@ast
Enhanced endocannabinoid signaling elevates neuronal excitability in fragile X syndrome.
@en
Enhanced endocannabinoid signaling elevates neuronal excitability in fragile X syndrome.
@nl
type
label
Enhanced endocannabinoid signaling elevates neuronal excitability in fragile X syndrome.
@ast
Enhanced endocannabinoid signaling elevates neuronal excitability in fragile X syndrome.
@en
Enhanced endocannabinoid signaling elevates neuronal excitability in fragile X syndrome.
@nl
prefLabel
Enhanced endocannabinoid signaling elevates neuronal excitability in fragile X syndrome.
@ast
Enhanced endocannabinoid signaling elevates neuronal excitability in fragile X syndrome.
@en
Enhanced endocannabinoid signaling elevates neuronal excitability in fragile X syndrome.
@nl
P2860
P1476
Enhanced endocannabinoid signaling elevates neuronal excitability in fragile X syndrome.
@en
P2093
Bradley E Alger
Longhua Zhang
P2860
P304
P356
10.1523/JNEUROSCI.0795-10.2010
P407
P577
2010-04-01T00:00:00Z